New approaches to standard of care in early-phase myeloproliferative neoplasms: can interferon-α alter the natural history of the disease? by Florence Pasquier, Jean Pegliasco, Jean-Edouard Martin, Severine Marti, Isabelle Plo

Get full text

Pilot cadaveric study on the feasibility of cricothyroidotomy and the associated complications in 30 cats by Julia A. Delle Cave, Samuel R. Larcheveque, Edouard Martin, Elizabeth O’Toole

Get full text

Germline RUNX1 Intragenic Deletion: Implications for Accurate Diagnosis of FPD/AML by Nicolas Duployez, Jean-Edouard Martin, Sabine Khalife-Hachem, Ryane Benkhelil, Véronique Saada, Christophe Marzac, Nathalie Auger, Alice Marceau-Renaut, Rémi Favier, Paola Ballerini, Olivier Caron, André Baruchel, Stéphane de Botton, Claude Preudhomme, Jean-Baptiste Micol, Hana Raslova, Iléana Antony-Debré

Get full text

ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis by Francesca Basso-Valentina, Alessandro Donada, Vladimir T Manchev, Manuel Lisetto, Nathalie Balayn, Jean Edouard Martin, Delphine Muller, Cecilia Paola Marin Oyarzun, Hélène Duparc, Brahim Arkoun, Alessandro Cumin, Lionel Faivre, Nathalie Droin, Ida Biunno, Alessandro Pecci, Alessandra Balduini, Najet Debili, Iléana Antony-Debré, Caroline Marty, William Vainchenker, Isabelle Plo, Remi Favier, Hana Raslova

Get full text